ProPublica

• Over 700 Doctors Paid More Than $1 Million by Drug, Medical Device Companies ProPublica has been tracking drug company spending on doctors since 2010. We just updated our database and found that companies are still paying private doctors huge sums for promotional talks and consulting.
  ProPublica, October 2019
• Doctor Who Advocated 'Unethical' Care of Vegetative Patient Is Placed on Leave Newark Beth Israel acted after our report that its transplant program kept a patient alive to improve its metrics, while barely consulting his family.
  ProPublica, October 2019
• Boston Hospital Reports Disciplining of Child Abuse Skeptic Last September, ProPublica examined Dr Michael Holick's work as an expert witness for alleged abusers. His hospital has notified Massachusetts' medical board that it restricted his privileges.
  ProPublica, July 2019
• Health Insurers Make It Easy for Scammers to Steal Millions Health insurers are regarded as fierce defenders of health care dollars. But the case of David Williams shows one reason America's health care costs continue to rise. The personal trainer spent years posing as a doctor and billing the nation's top insurers, making off with millions.
  ProPublica, July 2019
• One Cardiac Arrest. Four 911 Callers. A Tragic Outcome. Rhode Island's 911 operators are unprepared to handle cardiac arrest calls, and Rena Fleury, 45, lost her life.
  ProPublica, June 2019
• University of Illinois Missed Warning Signs of Research Going Awry UIC has played down its shortcomings in overseeing the work of a prominent child psychiatrist, but newly obtained documents show that the school acknowledged its lapses to federal officials.
  ProPublica, April 2019
• Sackler Embraced Plan to Conceal OxyContin's Strength From Doctors Richard Sackler, whose family has reaped billions of dollars from OxyContin, boasted that sales exceeded his 'fondest dreams,' according to a secret court document obtained by ProPublica.
  ProPublica, February 2019
• OxyContin Maker Explored Expansion Into Anti-Addiction Market Secret portions of a lawsuit allege that Purdue Pharma considered capitalizing on the addiction treatment boom — while going to extreme lengths to boost sales of its controversial opioid.
  ProPublica, January 2019
• St. Luke's Replaces President, Other Leaders After Series of Care Lapses Ouster comes 5 months after the Centers for Medicare and Medicaid Services terminated federal funding for heart transplants at the 65-year-old hospital, citing a failure to make needed changes.
  ProPublica, January 2019
• MSK Curbs Executives' Ties to Industry After Conflict-of-Interest Scandals Memorial Sloan Kettering Cancer Center will bar its top executives from serving on corporate boards of drug and healthcare companies that, in some cases, had paid them hundreds of thousands of dollars a year.
  ProPublica, January 2019
• Top Doctors Aren't Disclosing Industry Ties in Journal Studies The dean of Yale's medical school, the incoming president of a prominent cancer group, and the head of a Texas cancer center are among those who have not accurately disclosed their ties with drug companies.
  ProPublica, December 2018
• Medical Devices Not Keeping Health Data to Themselves CPAP units, heart monitors, blood glucose meters and lifestyle apps generate information that can be used in ways patients don’t necessarily expect.
  ProPublica, November 2018
• Cancer Researchers Correct the Record by Revealing Company Ties The hospital’s chief medical officer resigned last month after failing to disclose company ties in medical journals. Now, Memorial Sloan Kettering researchers, including chief executive Dr. Craig B. Thompson, are updating their own conflict-of-interest disclosures.
  ProPublica, October 2018
• A Surgeon So Bad It Was Criminal Christopher Duntsch's surgical outcomes were so outlandishly poor that Texas prosecuted him for harming patients.
  ProPublica, October 2018
• Black Patients Miss Out on Promising Cancer Drugs A ProPublica analysis found that black people and Native Americans are underrepresented in clinical trials of new drugs, even when the treatment is aimed at a type of cancer that disproportionately affects them.
  ProPublica, September 2018
• Sloan Kettering's Cozy Deal With Start-Up Ignites a New Uproar A for-profit venture with exclusive rights to use the cancer center’s vast archive of tissue slides has generated concerns among pathologists at the hospital, as well as experts in nonprofit law and corporate governance.
  ProPublica, September 2018
• NYC Launches Initiative to Eliminate Racial Disparities in Maternal Death A Central Brooklyn hospital featured in ProPublica and NPR’s “Lost Mothers” series for its high hemorrhage rate will serve as a pilot for quality reforms.
  ProPublica, August 2018
• Senate Committee Proposes $50 Million to Prevent Maternal Death After years of Congressional inaction, legislators in both parties want to back efforts by states and hospitals to reduce the U.S. maternal mortality rate, the highest in the developed world.
  ProPublica, July 2018
• Opioid Makers Cut Back on Marketing Payments to Doctors As ProPublica updates Dollars for Docs, we found that drugmakers spent less money to market opioids to doctors in 2016 than in prior years. Studies have shown that payments to doctors by opioid makers are linked to more prescribing of the drugs.
  ProPublica, July 2018
• FDA Repays Industry by Rushing Risky Drugs to Market As pharma companies underwrite three-fourths of the FDA’s budget for scientific reviews, the agency is increasingly fast-tracking expensive drugs with significant side effects and unproven health benefits.
  ProPublica, July 2018